Defibrillators Market by Product (T-ICDs, S-ICDs, CRT-D, MED, AED, WCD) and End-User (Hospitals, Prehospital, Public Access, Alternate Care, Home) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

  • ID: 3773190
  • Report
  • Region: Global
  • 150 pages
  • Allied Analytics LLP
1 of 5

FEATURED COMPANIES

  • Biotronik SE & Co. KG
  • Defibtech
  • Koninklijke Philips N.V.
  • LivaNova PLC
  • Medtronic plc
  • Nihon Kohden Corporation
  • MORE
Defibrillators are devices used to deliver therapeutic shock to a patient’s heart in life-threatening conditions such as ventricular fibrillation, cardiac arrhythmia, and pulseless ventricular tachycardia. The defibrillation procedure encompasses delivery of an electric shock to the heart, which depolarizes heart muscles and restores its normal electric impulse. Growing focus towards public access defibrillator (PAD) by the public & private organizations, along with the key players, has fuelled the market growth. Other factors such as technologically advanced defibrillator devices, rapidly growing geriatric population with elevated risk of targeted diseases, and increasing incidence of cardiac diseases are driving the market growth. However, frequent product recalls, increasing pricing pressure on players and lack of awareness about sudden cardiac arrest (SCA) are restraining the growth of this market.

The world defibrillators market is segmented on the basis of product, end user, and geography. On the basis of product, the world defibrillator market is further segmented into implantable defibrillators and external defibrillators. Implantable defibrillators are further categorized into cardiac resynchronisation therapy- defibrillator (CRT-D), transvenous implantable cardioverter defibrillator (T-ICDs) and subcutaneous implantable cardioverter defibrillator (S-ICDs). Among these, the T-ICDs segment dominates the overall ICD market owing to higher precision and targeted functioning. In addition, external defibrillators segment is further categorized into manual external defibrillator, automated external defibrillator (AEDs), and wearable cardioverter defibrillator (WCDs).

On the basis of end user, the defibrillator market is segmented into hospitals, prehospital, public access market, alternative care market, and home. Geographically, the market is segmented across four major regions such as North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in the defibrillators market. The growth in this region is mainly due to factors such as product innovations, growing number of public defibrillation programs, and rising prevalence of chronic diseases. In addition, the Asia-Pacific region is expected to emerge as the area with maximum growth potential due to the growing focus of key players in emerging economies, improving healthcare infrastructure, and rising number of cardiovascular diseases.

The report provides a comprehensive analysis of the key players operating in the world defibrillators market such as Asahi Kasei Corporation, Stryker Corporation, Biotronik SE & Co. KG, Boston Scientific Corporation, Philips Healthcare, LivaNova PLC, Medtronic plc, Cardiac Science Corporation, Nihon Kohden Corporation, and St. Jude Medical, Inc.

Key Benefits of the Report
- The study provides an in-depth analysis of the world neuromodulation market with current trends and future estimations to elucidate the imminent investment pockets.
- The report provides a quantitative analysis from 2014 to 2022, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
- The report provides actual historical figures for 2014 and 2015 and provides Y-o-Y forecasts for 2016 to 2022, considering 2015 as base.
- Extensive analysis by product helps in understanding the various types of devices used for the treatment of neurological diseases and other related conditions.
- Competitive intelligence highlights the business practices followed by leading players across various regions.
- SWOT analysis studies the internal environment of the leading companies for strategy formulation.

KEY MARKET SEGMENTS:
The world defibrillators market is segmented into product, end user, and geography.

- By Product
Implantable Defibrillators
- Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
- Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)
- Cardiac Resynchronization Therapy- Defibrillator (CRT-D)
 External Defibrillators
- Manual External Defibrillator
- Automated External Defibrillator (AEDs),
- Wearable Cardioverter Defibrillator (WCDs).

- By End User
Hospitals
 Pre-hospitals
 Public Access market
 Alternate Care Market
 Home

- By Geography

 North America
- U.S.
- Canada
- Mexico

 Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe

 Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific

LAMEA
- Brazil
- Argentina
- Egypt
- Israel
- South Africa
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Biotronik SE & Co. KG
  • Defibtech
  • Koninklijke Philips N.V.
  • LivaNova PLC
  • Medtronic plc
  • Nihon Kohden Corporation
  • MORE
CHAPTER 1 INTRODUCTION
1.1 Report Description
1.2 Key Benefits
1.3 Key Market Segments
1.4 Research Methodology
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Analyst Tools and Models

CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO Perspective

CHAPTER 3 MARKET OVERVIEW
3.1 Market Definition And Scope
3.2 Key Findings
3.2.1 Top Investment Pockets
3.2.2 Top Winning Strategies
3.3 Porter’s Five Forces Analysis
3.3.1 High competition and fragmented market moderate the power of the suppliers
3.3.2 Scattered and large number of buyers moderate their bargaining power
3.3.3 High capital investment moderates the threat of new entrants
3.3.4 High intensity of rivalry
3.3.5 Unavailability of substitutes lowers the threat of substitutes
3.4 Market Share Analysis, 2015
3.5 Market Dynamics
3.5.1 Drivers
3.5.1.1 Growing incidence of sudden cardiac arrest (SCA) and cardiovascular diseases across the globe
3.5.1.2 Technological advancements in defibrillators
3.5.1.3 Increasing patient awareness
3.5.1.4 High presence of unmet medical needs
3.5.2 Restraints
3.5.2.1 Limited insurance coverage and high cost of the defibrillators
3.5.2.2 preference of drugs over defibrillators
3.5.3 Opportunities
3.5.3.1 Lucrative opportunities in emerging economies
3.5.3.2 Development of new MRI-labeled devices

CHAPTER 4 WORLD DEFRIBILLATORS MARKET, BY PRODUCT
4.1 Overview
4.2 Implantable Cardioverter Defibrillators (ICDs)
4.2.1 Key Market Trends
4.2.2 Key Growth Factors and Opportunities
4.2.3 Market Size and Forecast
4.2.3.1 Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
4.2.3.1.1 MARKET SIZE AND FORECASTS
4.2.3.2 Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)
4.2.3.2.1 MARKET SIZE AND FORECASTS
4.2.3.3 CRT with pacemaker and ICD function (CRT-D)
4.2.3.3.1 MARKET SIZE AND FORECASTS
4.3 External Defibrillator
4.3.1 Key Market Trends
4.3.2 Key Growth Factors and Opportunities
4.3.3 Market Size and Forecast
4.3.4 Manual External Defibrillator
4.3.4.1 Market size and forecast
4.3.5 Automated External Defibrillator (AEDs)
4.3.5.1 Market size and forecast
4.3.5.2 Semi-automated EXTERNAL DEFIBRILLATOR
4.3.5.2.1 MARKET SIZE AND FORECAST
4.3.5.3 Fully automated External Defibrillator
4.3.5.3.1 MARKET SIZE AND FORECAST
4.3.6 Wearable Cardioverter Defibrillator (WCDs)
4.3.6.1 Market size and forecast

CHAPTER 5 WORLD DEFRIBILLATORS MARKET, BY END USER
5.1 Overview
5.1.1 Market Size and Forecast
5.2 Hospitals
5.2.1 Market Size and Forecast
5.3 Prehospital
5.3.1 Market Size and Forecast
5.4 Public Access Market
5.4.1 Market Size and Forecast
5.5 Alternate Care Market
5.5.1 Market Size and Forecast
5.6 Home
5.6.1 Market Size and Forecast

CHAPTER 6 DEFIBRILLATORS MARKET, BY GEOGRAPHY, 2015–2022
6.1 Overview
6.1.1 Market Size and Forecast
6.2 North America
6.2.1 Key Market Trends
6.2.2 Key Growth Factors and Opportunities
6.2.3 Market Size and Forecast
6.2.3.1 U.S. Market size and forecast
6.2.3.2 Canada Market size and forecast
6.2.3.3 Mexico Market size and forecast
6.3 Europe
6.3.1 Key Market Trends
6.3.2 Key Growth Factors and Opportunities
6.3.3 Market Size and Forecast
6.3.3.1 U.K. Market size and forecast
6.3.3.2 France Market size and forecast
6.3.3.3 Germany Market size and forecast
6.3.3.4 Italy Market size and forecast
6.3.3.5 Spain Market size and forecast
6.3.3.6 Rest of Europe Market size and forecast
6.4 Asia-Pacific
6.4.1 Key Market Trends
6.4.2 Key Growth Factors and Opportunities
6.4.3 Market Size and Forecast
6.4.3.1 Japan Market size and forecast
6.4.3.2 China Market size and forecast
6.4.3.3 India Market size and forecast
6.4.3.4 Australia Market size and forecast
6.4.3.5 Rest of Asia-Pacific Market size and forecast
6.5 LAMEA
6.5.1 Key Market Trends
6.5.2 Key Growth Factors and Opportunities
6.5.3 Market Size and Forecast
6.5.3.1 Brazil Market size and forecast
6.5.3.2 Argentina Market size and forecast
6.5.3.3 Egypt Market size and forecast
6.5.3.4 Israel Market size and forecast
6.5.3.5 South Africa Market size and forecast

CHAPTER 7 COMPANY PROFILES
7.1 Asahi Kasei Corporation
7.1.1 Company Overview
7.1.2 Company Snapshot
7.1.3 Operating Business Segments
7.1.4 Business Performance
7.1.5 Key Strategic Moves and Developments
7.1.6 SWOT Analysis
7.2 Stryker Corporation
7.2.1 Company Overview
7.2.2 Company Snapshot
7.2.3 Operating Business Segments
7.2.4 Business Performance
7.2.5 Key Strategic Moves and Development
7.2.6 SWOT Analysis
7.3 Biotronik SE & Co. KG
7.3.1 Company Overview
7.3.2 Company Snapshot
7.3.3 Operating Business Segments
7.3.4 Key Strategic Moves & Developments
7.3.5 SWOT Analysis
7.4 Boston Scientific Corporation
7.4.1 Company Overview
7.4.2 Company Snapshot
7.4.3 Operating Business Segments
7.4.4 Business Performance
7.4.5 Key Strategic Moves and Developments
7.4.6 SWOT Analysis
7.5 Philips Healthcare (A Division of Koninklijke Philips N.V.)
7.5.1 Company Overview
7.5.2 Company Snapshot
7.5.3 Operating Business Segments Overview
7.5.4 Business Performance
7.5.5 SWOT Analysis
7.6 LivaNova PLC
7.6.1 Company Overview
7.6.2 Company Snapshot
7.6.3 Operating Business Segments
7.6.4 Business Performance
7.6.5 Key Strategic Moves and Developments
7.6.6 SWOT Analysis
7.7 Medtronic plc
7.7.1 Company Overview
7.7.2 Company Snapshot
7.7.3 Operating Business Segments
7.7.4 Business Performance
7.7.5 Key Strategic Moves and Developments
7.7.6 SWOT Analysis
7.8 St. Jude Medical, Inc.
7.8.1 Company Overview
7.8.2 Company Snapshot
7.8.3 Operating Business Segments
7.8.4 Business Performance
7.8.5 Key Strategic Moves and Developments
7.8.6 SWOT Analysis
7.9 Cardiac Science Corporation
7.9.1 Company Overview
7.9.2 Company Snapshot
7.9.3 Operating Business Segments
7.9.4 Key Strategic Moves and Developments
7.9.5 SWOT Analysis
7.10 NIHON KODEN CORPORATION
7.10.1 Company Overview
7.10.2 Company Snapshot
7.10.3 Operating Business Segments
7.10.4 Business Performance
7.10.5 Key Strategic Moves and Developments
7.10.6 SWOT Analysis

List Of Tables
Table 1 World Defibrillator Market, By Product Type, Volume, 2014–2022 (Unit)
Table 2 World Defibrillator Market, By Product Type, 2014–2022 ($Million)
Table 3 World Icds Market, By Type, Volume, 2014–2022 (Unit)
Table 4 World Icds Market, By Type, 2014–2022 ($Million)
Table 5 World Icds Market, By Geography, 2014–2022 ($Million)
Table 6 World External Defibrillators Market, By Type, Volume, 2014–2022 (Unit)
Table 7 World External Defibrillators Market, By Type, 2014–2022 ($Million)
Table 8 External Defibrillators Market, By Geography, 2014–2022 ($Million)
Table 9 World Automated External Defibrillators (Aeds) Market, By Type, 2015–2022 ($Million)
Table 10 World Defibrillators Market, By End User, 2014–2022 ($Million)
Table 11 World Defibrillators Market, By Geography, 2014–2022 ($Million)
Table 12 World Defibrillators Market, By Product Type, 2014–2022 ($Million)
Table 13 World: Defibrillators Market, By End User, 2014–2022 ($Million)
Table 14 North America: Defibrillators Market, By Country, 2014–2022 ($Million)
Table 15 North America: Defibrillators Market, By Product Type, 2014–2022 ($Million)
Table 16 North America: Defibrillators Market, By End User, 2014–2022 ($Million)
Table 17 North America: Icds Market, By Country, 2014–2022 ($Million)
Table 18 North America: External Defibrillator Market, By Country, 2014–2022 ($Million)
Table 19 Europe: Defibrillators Market, By Country, 2014–2022 ($Million)
Table 20 Europe: Defibrillators Market, By Product Type, 2014–2022 ($Million)
Table 21 Europe: Defibrillators Market, By End User, 2014–2022 ($Million)
Table 22 Europe: Icds Market, By Country, 2014–2022 ($Million)
Table 23 Europe: External Defibrillators Market, By Country, 2014–2022 ($Million)
Table 24 Asia-Pacific: Defibrillators Market, By Country, 2014–2022 ($Million)
Table 25 Asia-Pacific: Defibrillators Market, By Product Type, 2014–2022 ($Million)
Table 26 Asia-Pacific: Defibrillators Market, By End User, 2014–2022 ($Million)
Table 27 Asia-Pacific: Icds Market, By Country, 2014–2022 ($Million)
Table 28 Asia-Pacific: External Defibrillators Market, By Country, 2014–2022 ($Million)
Table 29 Lamea: Defibrillators Market, By Country, 2014–2022 ($Million)
Table 30 Lamea: Defibrillators Market, By Product Type, 2014–2022 ($Million)
Table 31 Lamea: Defibrillators Market, By End User, 2014–2022 ($Million)
Table 32 Lamea: Icds Market, By Country, 2014–2022 ($Million)
Table 33 Lamea: External Defibrillators Market, By Country, 2014–2022 ($Million)
Table 34 Zoll Medical Corporation: Company Snapshot
Table 35 Stryker Corporation: Company Snapshot
Table 36 Biotronik: Company Snapshot
Table 37 Biotronik: Operating Segments
Table 38 Boston Scientific Corporation: Company Snapshot
Table 39 Boston Scientific Corporation: Operating Segments
Table 40 Philips Healthcare: Snapshot
Table 41 Table 2 Philips: Operating Segments
Table 42 Livanova: Company Snapshot
Table 43 Livanova: Operating Segments
Table 44 Medtronic: Company Snapshot
Table 45 Medtronic: Operating Segments
Table 46 St. Jude Medical: Company Snapshot
Table 47 St. Jude Medical: Product Categories
Table 48 Cardiac Science Corporation: Company Snapshot
Table 49 Cardiac Science Corporation: Operating Segments
Table 50 Nihon Kohden: Company Snapshot
Table 51 Nihon Kohden: Operating Segments

List Of Figures
Fig. 1 Top Investment Pockets In World Defibrillators Market
Fig. 2 Top Winning Strategies: Percentage Distribution, 2014–2016
Fig. 3 Top Winning Strategies: Nature And Type
Fig. 4 Porter’S Five Forces Analysis
Fig. 5 Market Share Analysis, 2015
Fig. 6 Top Impacting Factors: World Defibrillators Market
Fig. 7 World Transvenous Implantable Cardioverter Defibrillator (T-Icds) Market, 2014–2022 ($Million)
Fig. 8 World Subcutaneous Implantable Cardioverter Defibrillator (S-Icds) Market, 2014–2022 ($Million)
Fig. 9 World Crt-D Defribillators Market, 2014–2022 ($Million)
Fig. 10 World Manual External Defibrillator Market, 2014–2022 ($Million)
Fig. 11 World Semi-Automated External Defibrillator (Aed) Market, 2014–2022 ($Million)
Fig. 12 World Fully-Automated Defibrillator Market, 2014–2022 ($Million)
Fig. 13 World Wearable External Defibrillator Market, 2014–2022 ($Million)
Fig. 14 World Defibrillators Market For Hospitals, 2014–2022 ($Million)
Fig. 15 World Defibrillators Market For Prehospital, 2014–2022 ($Million)
Fig. 16 World Defibrillators Market For Public Access Defibrillation, 2014–2022 ($Million)
Fig. 17 World Defibrillators Market For Alternate Care Market, 2014–2022 ($Million)
Fig. 18 World Defibrillators Market For Home, 2014–2022 ($Million)
Fig. 19 U.S. Defibrillators Market, 2014–2022 ($Million)
Fig. 20 Canada Defibrillators Market, 2014–2022 ($Million)
Fig. 21 Mexico Defibrillators Market, 2014–2022 ($Million)
Fig. 22 U.K. Defibrillators Market, 2014–2022 ($Million)
Fig. 23 France Defibrillators Market, 2014–2022 ($Million)
Fig. 24 Germany Defibrillators Market, 2014–2022 ($Million)
Fig. 25 Italy Defibrillators Market, 2014–2022 ($Million)
Fig. 26 Spain Defibrillators Market, 2014–2022 ($Million)
Fig. 27 Rest Of Europe Defibrillators Market, 2014–2022 ($Million)
Fig. 28 Japan Defibrillators Market, 2014–2022 ($Million)
Fig. 29 China Defibrillators Market, 2014–2022 ($Million)
Fig. 30 India Defibrillators Market, 2014–2022 ($Million)
Fig. 31 Australia Defibrillators Market, 2014–2022 ($Million)
Fig. 32 Rest Of Asia-Pacific Defibrillators Market, 2014–2022 ($Million)
Fig. 33 Brazil Defibrillators Market, 2014–2022 ($Million)
Fig. 34 Argentina Defibrillators Market, 2014–2022 ($Million)
Fig. 35 Egypt Defibrillators Market, 2014–2022 ($Million)
Fig. 36 Israel Defibrillators Market, 2014–2022 ($Million)
Fig. 37 South Africa Defibrillators Market, 2014–2022 ($Million)
Fig. 38 Asahi Kasei Corporation: Net Revenue, 2012–2014($Million)
Fig. 39 Asahi Kasei Corporation: Revenue, By Segment, 2015 (%)
Fig. 40 Asahi Kasei Corporation: Healthcare Group Revenue, By Subsegment, 2015 (%)
Fig. 41 Asahi Kasei Corporation: Swot Analysis
Fig. 42 Stryker Corporation: Net Sales, 2013–2015 ($Million)
Fig. 43 Stryker Corporation: Revenue, By Segment, 2015 (%)
Fig. 44 Stryker Corporation: Revenue, By Geography, 2015 (%)
Fig. 45 Stryker Corporation: Swot Analysis
Fig. 46 Biotronik: Swot Analysis
Fig. 47 Boston Scientific Corporation: Net Sales, 2013–2015, ($Million)
Fig. 48 Boston Scientific Corporation: Revenue, By Business Segment, 2015 (%)
Fig. 49 Boston Scientific Corporation: Rhythm Management Revenue, By Subsegment, 2015 (%)
Fig. 50 Boston Scientific Corporation: Revenue, By Geography, 2015 (%)
Fig. 51 Boston Scientific Corporation: Swot Analysis
Fig. 52 Philips: Revenue, 2013–2015 ($Million)
Fig. 53 Philips: Revenue, By Segments, 2015 (%)
Fig. 54 Philips: Healthcare Revenue, By Subsegment, 2015 (%)
Fig. 55 Philips: Revenue, By Geography, 2015 (%)
Fig. 56 Philips Healthcare: Swot Analysis
Fig. 57 Livanova: Net Sales, 2013–2015 ($Million)
Fig. 58 Livanova: Revenue, By Business Segments, 2015 (%)
Fig. 59 Livanova: Revenue, By Geography, 2015 (%)
Fig. 60 Livanova: Revenue, By Geography, 2015 (%)
Fig. 61 Livanova: Swot Analysis
Fig. 62 Medtronic: Net Sales, 2013–2015 ($Million)
Fig. 63 Medtronic: Revenue, By Segment, 2015 (%)
Fig. 64 Medtronic: Cardiac And Vascular Group Revenue, By Subsegment, 2015 (%)
Fig. 65 Medtronic: Swot Analysis
Fig. 66 St. Jude Medical: Net Sales, 2013–2015 ($Million)
Fig. 67 St. Jude Medical: Revenue, By Principle Product Category, 2015 (%)
Fig. 68 St. Jude Medical: Revenue, By Geography, 2015 (%)
Fig. 69 St. Jude Medical: Swot Analysis
Fig. 70 Cardiac Science Corporation: Swot Analysis
Fig. 71 Nihon Koden: Revenue, 2013–2015($Million)
Fig. 72 Nihon Koden: Revenue, By Segments, 2015(%)
Fig. 73 Nihon Koden: Revenue, By Geography, 2015(%)
Fig. 74 Nihon Kohden: Swot Analysis
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Biotronik SE & Co. KG
  • Defibtech
  • Koninklijke Philips N.V.
  • LivaNova PLC
  • Medtronic plc
  • Nihon Kohden Corporation
  • MORE
A new report titled, "Defibrillator Market - Global Opportunity Analysis and Industry Forecast, 2014 - 2022", projects that the global defibrillators market would reach $15,610 million by 2022. Implantable cardioverter defibrillators (ICDs) segment is expected to dominate this market throughout 2015 and 2022. North America would continue to lead, accounting for more than two-fifths share of the global defibrillator market in 2015.

Advent of automated external defibrillators (AEDs) for public access places, rising incidences of sudden cardiac arrest, and growing awareness towards public access defibrillators worldwide are the factors majorly driving the market growth. The rising number of application areas for defibrillators, coupled with increasing adoption of defibrillator systems (both ICDs and external defibrillators) in cardiology, is expected to boost the global defibrillators market growth. Cost-effectiveness, safety, high accessibility, and clinical value in preliminary treatment of sudden cardiac arrest strengthen the technological advancements in this market. In addition, increase in number of advanced implantable cardiac defibrillators (S-ICDs, T-ICDs, and CRT-D) and awareness about early treatment of life threatening cardiac diseases (such as cardiac arrhythmia, ventricular fibrillation, and sudden cardiac arrest) are anticipated to further drive the demand for defibrillators globally. However, unawareness, unfavorable healthcare reforms, certain issues related to (external and implantable) defibrillators are the limitations that restrict the market growth.

The transvenous-implantable cardioverter defibrillator (T-ICDs) segment accounted for about 95% of the overall ICD market in 2015, as these are the most commonly used ICDs for the treatment of heart disorders for higher precision and targeted functioning. In addition, cardiac resynchronization therapy defibrillator (CRT-D) is the fastest growing segment and is projected to register a CAGR 5.0% during the forecast period. This is due to the growing demand of defibrillator that helps in restoring the heart back to a normal pace from faster heart rhythms and to prevent the heart rate to go below normal levels.

Automated external defibrillator (AEDs) segment is projected to maintain its lead in the overall external defibrillators market due to its increasing installations at public or private places such as schools, work place, airports, sports arenas, government offices, and others. The growing demand of AEDs in the developed economies of North America and Europe have further boosted the market growth. Furthermore, wearable external defibrillator is anticipated to exhibit the highest growth, with a CAGR of 12.3% during the forecast period. This is owed to the advanced protection by these defibrillators for sudden cardiac arrest and increase in demand from home healthcare facilities.

The ability of the defibrillator device to diagnose early onset of ventricular tachycardia and ventricular defibrillation is expected to promote its demand. On the other hand, the life-saving potential of automated external defibrillators (AEDs) in addition to positive legislations for installation of public access defibrillators (PAD) has witnessed the remarkable growth in the defibrillator market, states Hemali Narkhede, Manager, Healthcare Research at AMR. Also, stiff competition in the U.S. market has resulted in significant decrease in the cost of AEDs. The enforcement of the U.S. governmental law, which necessitates the installation of public access defibrillators (PAD) at public places has derived the growth of AEDs in this region.

However, Asia-Pacific is projected to be the fastest growing region throughout the analysis period. Japan, being dominant in the Asia-Pacific especially in external defibrillator market, contributes solely for the AEDs market share. This is a result of awareness about the early prevention of sudden cardiac arrest. Also, improving healthcare infrastructures and increasing expenditures in the emerging markets (such as India and China) to overcome the unmet medical needs in these countries have bolstered the market growth. Technological advancements for cost-effective devices in these nations offer a lucrative opportunity for the defibrillator market growth.

Key Findings of Defibrillator Market:
In 2015, T-ICDs led the overall implantable defibrillator market revenue, and is projected to grow at a CAGR of 4.9% during the forecast period.
Wearable external defibrillator segment is expected to grow at a remarkable CAGR of 12.3%, owing to the non-invasive nature and increased demand of home healthcare for the treatment of sudden cardiac arrest.
Fully-automated defibrillator segment is projected to grow at a CAGR of 9.9% during the analysis period.
The automated external defibrillator (AEDs) is projected to generate the largest revenue in the external defibrillator market.
Japan is the major shareholder accounting for about half share of the Asia-Pacific defibrillators market.
The key players in the defibrillators market are focused on expanding their business operations in the fast-growing emerging countries with new product launches as a preferred strategy.

The major players profiled in this report include ZOLL Medical Corporation (a subsidiary of Asahi Kasei Corporation), Stryker Corporation, Biotronik SE & Co. KG, Boston Scientific Corporation, LivaNova PLC, Medtronic plc, Koninklijke Philips N.V., Defibtech, LLC, St. Jude Medical, Inc., Nihon Kohden Corporation, and Cardiac Science Corporation.
Note: Product cover images may vary from those shown
5 of 5
- ZOLL Medical Corporation (a subsidiary of Asahi Kasei Corporation)
- Stryker Corporation
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- LivaNova PLC
- Medtronic plc
- Koninklijke Philips N.V.
- Defibtech
- St. Jude Medical
- Nihon Kohden Corporation
- Cardiac Science Corporation.
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll